Short answer
Monte Rosa Therapeutics, Inc. (GLUE) filed an 8-K current report with the SEC on June 11, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders re-elected Andrew Schiff, Chandra P. Leo and Anthony Manning as Class II directors through 2029.
Monte Rosa Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Stockholders re-elected Andrew Schiff, Chandra P. Leo and Anthony Manning as Class II directors through 2029
- Schiff and Leo received over 71 million votes for, while Manning received 56,995,916 amid 15,154,289 votes withheld
- Deloitte & Touche LLP ratified as independent auditor for fiscal year ending December 31, 2026
- Auditor appointment received 75,171,524 votes for versus 57,950 against and 49,616 abstentions
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Monte Rosa Therapeutics, Inc. 8-K filings
Get the next GLUE 8-K as it lands
Follow GLUE for push alerts, or ask the research agent what this filing means.